BOULDER, Colo.--(BUSINESS WIRE)--SomaLogic, Inc., announced today that Novartis has extended its multi-year research agreement for the development and application of SomaLogic’s unique proteomics technology to Novartis’ drug discovery and development efforts. Novartis will also take an equity position in SomaLogic under the agreement extension.
Help employers find you! Check out all the jobs and post your resume.
